Budapest, Hungary

András Füredi

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Magyar Tudományos Akadémia Természettudományi Kutatóközpont. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: András Füredi. Retrieved from https://idiyas.com/inventor/andrás-füredi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: András Füredi: Innovator in Cancer Treatment

Introduction

András Füredi is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on addressing the challenges posed by multidrug-resistant cancer cells.

Latest Patents

Füredi holds a patent for "MDR-reversing 8-hydroxy-quinoline derivatives." This invention relates to 8-hydroxy-quinoline derivatives that exhibit multidrug-resistance reversing activity. These derivatives demonstrate improved selectivity and increased cytotoxicity towards multidrug-resistant cancer cells. The preparation and application of these compounds are aimed at enhancing cancer treatment, particularly for multidrug-resistant variants.

Career Highlights

Throughout his career, András Füredi has been associated with prestigious institutions such as the Hungarian Academy of Sciences Natural Science Research Center and Eötvös Loránd University. His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Füredi has collaborated with esteemed colleagues, including Gergely Szakács and Tibor Soós. These partnerships have fostered a collaborative environment that enhances the quality and impact of his research.

Conclusion

András Füredi's innovative work in developing multidrug-resistance reversing compounds represents a significant advancement in cancer treatment. His contributions continue to inspire further research in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…